Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 302–303 (2005)Cite this article

boxed-textLencioni R et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234: 961–967

Radiofrequency ablation should be the first-line treatment of choice for patients with early-stage hepatocellular carcinoma and cirrhosis who are ineligible for surgery

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. El-Serag HB and Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745–750

    Article  CAS  Google Scholar 

  2. Poon RT et al. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234: 63–70

    Article  CAS  Google Scholar 

  3. Llovet JM and Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38 (Suppl 1): S136–149

    Article  Google Scholar 

  4. Ng KK and Poon RT (2005) Radiofrequency ablation for malignant liver tumor. Surg Oncol 14: 41–52

    Article  Google Scholar 

  5. Lencioni RA et al. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228: 235–240

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Vascular and Interventional Radiology,

    Jean-Francois Geschwind & Eleni Liapi

  2. Division of Vascular and Interventional Radiology at the Johns Hopkins Hospital, Baltimore, MD, USA

    Jean-Francois Geschwind & Eleni Liapi

Authors
  1. Jean-Francois Geschwind
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleni Liapi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Francois Geschwind.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

RADIOFREQUENCY ABLATION (RFA)

Heat-induced tissue destruction using an electrical current that is passed through a needle electrode placed directly into the tissue

EARLY-STAGE HEPATOCELLULAR CARCINOMA

A single tumor ≥5 cm in diameter, or up to three lesions of ≥3 cm diameter

CHILD–TURCOTTE–PUGH SCORE

Prognostic score used in patients with cirrhosis, based on laboratory parameters (prothrombin time, serum albumin levels, total bilrubin) and clinical parameters (ascites and encephalopathy)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geschwind, JF., Liapi, E. Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?. Nat Rev Gastroenterol Hepatol 2, 302–303 (2005). https://doi.org/10.1038/ncpgasthep0210

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0210

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing